1. Angioimmunoblastic T-cell lymphoma: the effect of initial treatment and microvascular density in 31 patients

   • Shu Zhao
   • Liangyu Zhang
   • Qingyuan Zhang

   Original Paper 30 October 2011 Pages: 2311 - 2316

   

2. High expression of tumor-infiltrating macrophages correlates with poor prognosis in patients with diffuse large B-cell lymphoma

   • Qi-chun Cai
   • Hong Liao
   • Hui-qiang Huang

   Original Paper 24 December 2011 Pages: 2317 - 2322

   

3. Distinctive microRNA signature is associated with the diagnosis and prognosis of acute leukemia

   • Yuan-Dong Zhu
   • Li Wang
   • Wei Xu

   Original Paper 31 December 2011 Pages: 2323 - 2331

   

4. A new dic(7;12)(p12.21;p12.2) and i(12)(q10) during the lymphoid blast crisis of patient with Ph+ chronic myeloid leukemia

   • Fábio Morato de Oliveira
   • Leonardo de Carvalho Palma
   • Belinda Pinto Simões

   Short Communication 31 December 2011 Pages: 2332 - 2336

   

5. The relationship of the active and latent forms of TGF-β1 with marrow fibrosis in essential thrombocythemia and primary myelofibrosis

   • Cesar Cilento Ponce
   • Maria de Lourdes F. Chauffaille
   • Maria Regina R. Silva

   Original Paper 27 December 2011 Pages: 2337 - 2344

   

6. Acute promyelocytic leukemia associated with the PLZF-RARA fusion gene: two additional cases with clinical and laboratorial peculiar presentations

   • Sandra S. Rohr
   • Luís Arthur Flores Pelloso
   • Maria de Lourdes L. F. Chauffaille

   Short Communication 29 December 2011 Pages: 2345 - 2347

   

7. Different impact of intermediate and unfavourable cytogenetics at the time of diagnosis on outcome of de novo AML after allo-SCT: a long-term retrospective analysis from a single institution

   • H. Nahi
   • M. Remberger
   • H. Hägglund

   Original Paper 11 January 2012 Pages: 2348 - 2358

   

8. Hypermethylation of SHP-1 promoter in patient with high-risk myelodysplastic syndrome and it predicts poor prognosis

   • Yizhuo Zhang
   • Dandan Zhao
   • Wanming Da

   Original Paper 19 January 2012 Pages: 2359 - 2363

   

9. Prognostic significance of T cell subsets in peripheral blood of B cell non-Hodgkin’s lymphoma patients

   • Mehdi Dehghani
   • Shokouh Sharifpour
   • Hamid Reza Zare

   Original Paper 04 February 2012 Pages: 2364 - 2371

   

10. Comparison on therapeutic effects of RFT and RCTVP regimen in the treatment of patients with indolent B-cell lymphoma in China

    • Yun Hou
    • Hua-qing Wang
    • Yi Ba

    Original Paper 20 March 2012 Pages: 2372 - 2378

    

11. The JAK2V617F tyrosine kinase mutation has no impact on overall survival and the risk of leukemic transformation in myelofibrosis

    • Grzegorz Helbig
    • Agata Wieczorkiewicz
    • Sławomira Kyrcz-Krzemień

    Original Paper 01 March 2012 Pages: 2379 - 2384

    

12. Primary mantle cell lymphoma of the trachea

    • Achuta K. Guddati
    • Creticus P. Marak

    Case Report 06 March 2012 Pages: 2385 - 2387

    

13. Impaired apoptosis of megakaryocytes and bone marrow mononuclear cells in essential thrombocythemia: correlation with JAK2V617F mutational status and cytoreductive therapy

    • Jacek Treliński
    • Krzysztof Chojnowski
    • Piotr Smolewski

    Original Paper Open access 15 March 2012 Pages: 2388 - 2395

    

14. Serum concentrations and clinical significance of soluble CD40 ligand in patients with multiple myeloma

    • G. Tsirakis
    • C. A. Pappa
    • M. G. Alexandrakis

    Original Paper 09 March 2012 Pages: 2396 - 2401

    

15. Circulating microRNA expression is associated with genetic subtype and survival of multiple myeloma

    • Jing-jing Huang
    • Juan Yu
    • Ren-qian Zhong

    Original Paper 24 March 2012 Pages: 2402 - 2408

    

16. Rituximab, gemcitabine, cisplatin, and dexamethasone in patients with refractory or relapsed aggressive B-cell lymphoma

    • Yun Hou
    • Hua-qing Wang
    • Yi Ba

    Original Paper 03 April 2012 Pages: 2409 - 2416

    

17. Cutaneous blastic plasmacytoid dendritic cell neoplasm occurring after spontaneous remission of acute myeloid leukemia: a case report and review of literature

    • Wanzhuo Xie
    • Yanmin Zhao
    • He Huang

    Case Report 03 April 2012 Pages: 2417 - 2422

    

18. Progranulin overexpression predicts overall survival in patients with glioblastoma

    • Minqing Wang
    • Gang Li
    • Jian Zhang

    Original Paper 13 December 2011 Pages: 2423 - 2431

    

19. Increased expression of matrix metalloproteinase-13 in glioma is associated with poor overall survival of patients

    • Jun Wang
    • Yunming Li
    • Qingsong Wang

    Original Paper 17 February 2012 Pages: 2432 - 2437

    

20. Fascin expression in skull base chordoma: correlation with tumor recurrence and dura erosion

    • Ziyun Gao
    • Qiuhang Zhang
    • Feng Ling

    Original Paper 16 February 2012 Pages: 2438 - 2444

    

21. Role of Caspase 8, Caspase 9 and Bcl-2 polymorphisms in papillary thyroid carcinoma risk in Han Chinese population

    • Ying-Xue Wang
    • Lei Zhao
    • Su-Guo Yu

    Original Paper 26 November 2011 Pages: 2445 - 2451

22. Recurrent inflammatory pseudotumor of the jaw with perineural intracranial invasion demonstrating sustained response to Rituximab

    • Bryan A. Garcia
    • Sarah Tinsley
    • George C. Bobustuc

    Case Report 08 December 2011 Pages: 2452 - 2455

    

23. Late temporal lobe necrosis after conventional radiotherapy for carcinoma of maxillary sinus

    • Madhava R. Kanakamedala
    • Ali Mahta
    • Santosh Kesari

    Review Article 15 January 2012 Pages: 2456 - 2458

    

24. RETRACTED ARTICLE: Human papillomavirus-16 (HPV-16) infection association with CIAP-2 expression in head and neck cancer

    • Amal Mansour
    • Marwa Ali
    • Samar Kassim

    Original Paper 04 January 2012 Pages: 2459 - 2465

    

25. High expression of CXCR2 is associated with tumorigenesis, progression, and prognosis of laryngeal squamous cell carcinoma

    • Liang Han
    • Bin Jiang
    • Jin Zhu

    Original Paper 25 January 2012 Pages: 2466 - 2472

    

26. MicroRNA-34a affects the occurrence of laryngeal squamous cell carcinoma by targeting the antiapoptotic gene survivin

    • Zhisen Shen
    • Guowen Zhan
    • Junming Guo

    Original Paper 14 January 2012 Pages: 2473 - 2480

    

27. New approaches to EGFR inhibition for locally advanced or metastatic squamous cell carcinoma of the head and neck (SCCHN)

    • Mark Agulnik

    Review Article Open access 18 January 2012 Pages: 2481 - 2491

    

28. Single-nucleotide polymorphisms of integrins are associated with the risk and lymph node metastasis of oral squamous cell carcinoma

    • Xiang-Rui Ma
    • Hui Cheng
    • Dan Zhao

    Original Paper 21 January 2012 Pages: 2492 - 2498

    

29. Jun activation domain-binding protein 1 expression in oral squamous cell carcinomas inversely correlates with the cell cycle inhibitor p27

    • Ling Gao
    • Shuo Huang
    • Chen Huang

    Original Paper 04 February 2012 Pages: 2499 - 2504

    

30. Clinical significance of programmed cell death 4 expression in malignant progression of human nasal inverted papillomas

    • Yan Wang
    • Lingling Ding
    • Fei Gao

    Original Paper 23 February 2012 Pages: 2505 - 2511

    

31. Inhibition of silibinin on migration and adhesion capacity of human highly metastatic breast cancer cell line, MDA-MB-231, by evaluation of β1-integrin and downstream molecules, Cdc42, Raf-1 and D4GDI

    • Mohadeseh Dastpeyman
    • Nasrin Motamed
    • Mohammad Ali Shokrgozar

    Original Paper 19 November 2011 Pages: 2512 - 2518

    

32. Reduced expression of activin receptor-like kinase 7 in breast cancer is associated with tumor progression

    • Fancai Zeng
    • Guoxiong Xu
    • Hong Zhou

    Original Paper 16 November 2011 Pages: 2519 - 2526

    

33. Down-regulation of microRNA-200c is associated with drug resistance in human breast cancer

    • Junqing Chen
    • Wei Tian
    • Yongchuan Deng

    Original Paper 19 November 2011 Pages: 2527 - 2534

    

34. Reciprocal expression of survivin and SMAC/DIABLO in primary breast cancer

    • A. Mansour
    • M. Nabil
    • F. Annos

    Original Paper 08 December 2011 Pages: 2535 - 2542

    

35. Cells derived from normal or cancer breast tissue exhibit different growth properties when deprived of arginine

    • Angela Chiaviello
    • Ida Paciello
    • Salvatore M. Aloj

    Original Paper 20 December 2011 Pages: 2543 - 2551

    

36. Is there association between handedness and radiosensitivity in breast cancer women?

    • Meysam Khosravifarsani
    • Ali Shabestani Monfared
    • Mehrangiz Amiri

    Original Paper 05 January 2012 Pages: 2552 - 2555

    

37. Clinicopathologic characteristics and prognosis for molecular subtypes in low-grade breast carcinoma: comparison with grade one invasive ductal carcinoma-not otherwise specified

    • Shuling Wang
    • Weidong Li
    • Yun Niu

    Original Paper 07 February 2012 Pages: 2556 - 2564

    

38. Is HER2 overexpression sufficient for optimal response to Pertuzumab?

    • Mehmet Ali Nahit Şendur
    • Sercan Aksoy
    • Nurullah Zengin

    Letter to the Editor 16 February 2012 Pages: 2565 - 2566

39. Severe visual loss in a breast cancer patient on chemotherapy

    • Joan Giralt
    • Amanda Rey
    • Ricardo P. Casaroli-Marano

    Short Communication 22 February 2012 Pages: 2567 - 2569

    

40. Hypofractionation in post-mastectomy breast cancer patients: seven-year follow-up

    • Hany Eldeeb
    • Iman Awad
    • Osman Elhanafy

    Original Paper 22 February 2012 Pages: 2570 - 2576

    

41. Increased efficacy of a dose-dense regimen of neoadjuvant chemotherapy in breast carcinoma: a retrospective analysis

    • Bohuslav Melichar
    • Helena Hornychová
    • Aleš Ryška

    Original Paper 06 March 2012 Pages: 2577 - 2585

42. Role of HER2-neu as a prognostic factor for survival and relapse in pT1a–bN0M0 breast cancer: a systematic review of the literature with a pooled-analysis

    • F. Petrelli
    • S. Barni

    Review Article 14 March 2012 Pages: 2586 - 2593

    

43. Tumor-derived VEGF-C, but not VEGF-D, promotes sentinel lymph node lymphangiogenesis prior to metastasis in breast cancer patients

    • Ying-Chun Zhao
    • Xiao-Jian Ni
    • Shui Wang

    Original Paper 06 May 2012 Pages: 2594 - 2600

    

44. Demographic and clinico-pathological characteristics of breast cancer patients with history of oral alendronate use

    • Mehmet Ali Nahit Şendur
    • Sercan Aksoy
    • Kadri Altundağ

    Original Paper 15 March 2012 Pages: 2601 - 2605

    

45. P-cadherin expression and basal-like subtype in breast cancers

    • N. Liu
    • Q. Yu
    • Y. Niu

    Original Paper 01 April 2012 Pages: 2606 - 2612

    

46. Primary neuroendocrine breast cancer, how much do we know so far?

    • Homam Alkaied
    • Kassem Harris
    • Qun Dai

    Review Article 01 April 2012 Pages: 2613 - 2618

47. Prolonged activity of bevacizumab in adenocarcinoma of the lung with multiple brain metastases

    • Oana C. Danciu
    • Shayan Rayani
    • J. Lee Villano

    Short Communication 31 December 2011 Pages: 2619 - 2622

    

48. Chemotherapy-induced bowel obstruction in small cell lung cancer: a case report

    • Jermaine I. G. Coward
    • Nicola-Louise Ding
    • Piotr W. Szlosarek

    Short Communication 28 December 2011 Pages: 2623 - 2625

    

49. S100B protein as a possible participant in the brain metastasis of NSCLC

    • Xiaowen Pang
    • Jie Min
    • Helong Zhang

    Original Paper 28 January 2012 Pages: 2626 - 2632

    

50. Baseline and decline of serum ADAM28 during chemotherapy of advanced non-small cell lung cancer: a probable predictive and prognostic factor

    • Yan-ling Lv
    • Dong-mei Yuan
    • Yong Song

    Original Paper 22 February 2012 Pages: 2633 - 2639